跳至主要内容
临床试验/NCT03400839
NCT03400839Unknown不适用

Investigation of the Impact of Clinical Outcomes on Disease Progression and Prognosis in Patients With Interstitial Lung Diseases

Universidade Estadual de Londrina1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2017年9月15日最近更新:
适应症

试验速览

阶段
不适用
入组人数
105
试验地点
1
主要终点
Changes of daily steps over time

研究概览

简要总结

This prospective cohort study will investigate whether progression of the interstitial lung diseases is related to specific clinical endpoints and their changes over time. Longitudinal data of patients will be compared to an age-matched control group during a follow-up of at least two years.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with interstitial lung disease:
  • Age between 40 and 75 years old upon inclusion;
  • Diagnosis of interstitial lung disease;
  • Clinical stability for at least 4 weeks prior to inclusion;
  • Absence of any comorbidity that interferes with the performance of tests;
  • Age-matched control group:
  • Age between 40 and 75 years old upon inclusion;
  • Absence of any comorbidity that interferes with the performance of tests;
  • Exclusion Criteria (both groups):
  • Participants that present severe or unstable cardiac disease identified during the cardiopulmonary exercise testing;
  • Participants with cognitive deficit that interfere with any of the tests;

排除标准

  • 未提供

结局指标

主要结局

Changes of daily steps over time

时间窗: from date of inclusion until the date of study completion or until the documented date of death from any cause, whichever came first, up to 48 months

Changes in daily steps (measured using an activity monitor) at every 6-month interval until study completion or end of participation in the study.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Best Clinical Endpoints That Likely Induce Worse... | 临床试验